Organisation paid for research Program year 2025 Source: CMS Open Payments

Western Orthopaedics Research and Education Foundation

Neither a doctor nor a teaching hospital

Research payments

$762,850

53 payments

Through program year 2025, Western Orthopaedics Research and Education Foundation is reported as receiving $762,850 in research payments, across 53 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$64,115	4
2024	Research	$85,256	5
2023	Research	$139,865	3
2022	Research	$97,314	8
2021	Research	$162,503	13
2020	Research	$100,761	8
2019	Research	$113,035	12

Breakdown

Who paid Research payments · program years 2019–2025

Arthrex, Inc. $723,019 42 payments
Lima USA, Inc. $29,144 7 payments
Exactech, Inc. $10,687 4 payments

Studies the money was for Research payments · program years 2019–2025

Arthrex SOS Total Shoulder Registry $318,740 14 payments
Arthrex Total Shoulder Arthroplasty Registry $274,528 8 payments
Arthrex/Western Orthopaedics Research and Education Foundation research collaboration $53,600 4 payments
Eclipse Shoulder Prosthesis $33,999 4 payments
A Randomized, Multi-Center, Prospective, Safety and Efficacy Study comparing the outcome of total reverse shoulder arthroplasty (RSA) with SMR Stemless Reverse vs SMR Reverse Shoulder System $29,144 7 payments
Subscapularis repair in reverse shoulder arthroplasty $19,439 3 payments
Demineralized Bone Matrix Rotator Cuff Study (DBM RC) $19,242 3 payments
Eclipse Shoulder Prosthesis $1,560 1 payment
Eclipse Shoulder Prosthesis $711 2 payments
Demineralized Bone Matrix Rotator Cuff Study (DBM RC) $625 2 payments

What the money was spent on Research payments · program years 2019–2025

Overhead $85,256 5 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.